ValiRx ValiRx ValiBio ValiTherma ValiMedix
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Aim Rule 26
Live Quote
 
 
Aim Rule 26 Admission Document Advisors and Bankers Annual Reports Constitutional Document Corporate Governance Shareholders Information Shares in Issue Stock Information  

In addition to the information set out in this section, information as to the business of the Company as required by AIM Rule 26 can be found by clicking here - information as to the Directors of the Company and the committees formed, please click here. For more information about ValiRx plc, please see the About Us page.

ValiRx plc was incorporated in the UK under the Companies Act 1985, and its principle place of business is in the United Kingdom. The registered offices of ValiRx plc is set out below:

24 Greville Steet
London
EC1N 8SS
UK
Tel: +44 (0)203 0084416
Fax: +44 (0)203 0084415
Email: info@valirx.com

Registered in England and Wales
Company Number: 3916791
VAT Number: 756 3180 24

All announcements made in the last 12 months can be viewed in our Media Section.

Last Updated on 11 May 2009